Literature DB >> 9404382

Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma?

R Polosa1, S T Holgate.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404382      PMCID: PMC1758427          DOI: 10.1136/thx.52.10.919

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  39 in total

1.  Effect of indomethacin on adenosine-induced bronchoconstriction.

Authors:  N Crimi; F Palermo; R Polosa; R Oliveri; C Maccarrone; B Palermo; A Mistretta
Journal:  J Allergy Clin Immunol       Date:  1989-05       Impact factor: 10.793

2.  Adenosine potentiates mediator release from human lung mast cells.

Authors:  P T Peachell; M Columbo; A Kagey-Sobotka; L M Lichtenstein; G Marone
Journal:  Am Rev Respir Dis       Date:  1988-11

3.  The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5'-monophosphate, and allergen in atopic nonasthmatic subjects.

Authors:  G D Phillips; W H Ng; M K Church; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1990-01

Review 4.  Mucosal inflammation in asthma.

Authors:  R Djukanović; W R Roche; J W Wilson; C R Beasley; O P Twentyman; R H Howarth; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1990-08

5.  Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects.

Authors:  B J O'Connor; K F Chung; Y M Chen-Worsdell; R W Fuller; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1991-06

6.  The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma.

Authors:  G D Phillips; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-02

7.  Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma.

Authors:  G D Phillips; J P Finnerty; S T Holgate
Journal:  J Allergy Clin Immunol       Date:  1990-04       Impact factor: 10.793

8.  The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma.

Authors:  H Clarke; M J Cushley; C G Persson; S T Holgate
Journal:  Pulm Pharmacol       Date:  1989

9.  Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5'-monophosphate.

Authors:  G D Phillips; V L Scott; R Richards; S T Holgate
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

10.  Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease.

Authors:  A Avital; C Springer; E Bar-Yishay; S Godfrey
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

View more
  13 in total

Review 1.  Diagnostic and therapeutic value of airway challenges in asthma.

Authors:  Donald W Cockcroft; Beth E Davis
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

2.  Repeatability of bronchial hyperresponsiveness to adenosine-5'-monophosphate (AMP) by a short dosimeter protocol.

Authors:  G De Meer; D J Heederik; B Brunekreef; D S Postma
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

3.  Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.

Authors:  J P Hannon; B Tigani; I Williams; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects.

Authors:  R Polosa; C Pagano; G Prosperini; J L Low; D Dokic; M K Church; N Crimi
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

5.  Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.

Authors:  S Rorke; S Jennison; J A Jeffs; A P Sampson; H Arshad; S T Holgate
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

Review 6.  Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols.

Authors:  Sandra D Anderson; John D Brannan
Journal:  Clin Rev Allergy Immunol       Date:  2003-02       Impact factor: 8.667

7.  Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.

Authors:  René Aalbers; Martin Boorsma; Hanneke J van der Woude; René E Jonkers
Journal:  Respir Res       Date:  2010-05-28

8.  Role of endogenous adenosine in the acute and late response to allergen challenge in actively sensitized Brown Norway rats.

Authors:  K M Ellis; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 9.  Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease.

Authors:  R Polosa; S Rorke; S T Holgate
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

10.  Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.

Authors:  Graeme P Currie; Caroline E Bates; Daniel K C Lee; Catherine M Jackson; Brian J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  2003-03-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.